FOSUN PHARMA USA

SINCALIDE

Manufacturer:

FOSUN PHARMA USA

Sincalide HCPCS:

J2806

HCPCS Code Descriptor:

Injection, sincalide (maia) not therapeutically equivalent to j2805, 5 micrograms

Category:

J Code

Sincalide NDCs:

72266-0248-05, 72266-0248-01

Primary Type:

Radiopharmaceutical

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

72266-0248-01

About Sincalide:

SINCALIDE is a Radiopharmaceutical drug manufactured by FOSUN PHARMA USA and administered via the Intravenous route of administration. The J Code: J2806 is aligned to the drug SINCALIDE.

ACCESS PRICING AND MORE BY REGISTERING

J2806 Added Date:

July 1, 2023

J2806 Effective Date:

July 1, 2023

J2806 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Sincalide billing and coding information.
Our team did not identify a source for Sincalide patient assistance information. Please reach out to our team if you feel that this is a mistake.
SINCALIDE prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for SINCALIDE. Please check back in a few weeks.